Chemotherapy for early stage non-small cell lung cancer Journal Article
| Authors: | Kris, M. G.; Azzoli, C. G. |
| Article Title: | Chemotherapy for early stage non-small cell lung cancer |
| Abstract: | For patients with locally advanced non-small cell lung cancer (NSCLC) undergoing surgery, both induction and adjuvant chemotherapy improve survival and curability. Induction chemotherapy is also feasible for patients with early stage NSCLC. Randomized trials of induction treatment for early stage NSCLC, as well as induction and adjuvant treatment for Stage IIIA patients, are in progress. These trials should build on current successes, and add new approaches such as targeted therapies and vaccines, in an attempt to prevent metastases, recurrence, and second primary malignancies. Copyright © 2001 Elsevier Science Ireland Ltd. |
| Keywords: | cancer survival; unclassified drug; gene mutation; clinical trial; cancer recurrence; cisplatin; conference paper; adjuvant therapy; chemotherapy, adjuvant; neoadjuvant therapy; cancer staging; antineoplastic agent; neoplasm staging; neoplasm recurrence, local; etoposide; lung non small cell cancer; carcinoma, non-small-cell lung; lung neoplasms; granulocyte macrophage colony stimulating factor; cyclophosphamide; antineoplastic activity; protein tyrosine kinase; adjuvant chemotherapy; gefitinib; neoplasm metastasis; tumor vaccine; mitomycin; non-small cell lung cancer; ras; clinical trials; preoperative therapy; tegafur; thoracic surgery; uft; early stage; zd1839; humans; prognosis; human; priority journal |
| Journal Title: | Lung Cancer |
| Volume: | 34 |
| Issue: | Suppl. 3 |
| ISSN: | 0169-5002 |
| Publisher: | Elsevier Ireland Ltd. |
| Date Published: | 2001-12-01 |
| Start Page: | S49 |
| End Page: | S52 |
| Language: | English |
| PUBMED: | 11740994 |
| PROVIDER: | scopus |
| DOI: | 10.1016/S0169-5002(01)00372-5 |
| DOI/URL: | |
| Notes: | Export Date: 21 May 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work